AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $561 | -45.6% | 133 | -60.1% | 0.00% | – |
Q2 2023 | $1,032 | +271.2% | 333 | +66.5% | 0.00% | – |
Q1 2023 | $278 | -30.2% | 200 | 0.0% | 0.00% | – |
Q4 2022 | $398 | – | 200 | 0.0% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | – | 200 | +96.1% | 0.00% | – |
Q3 2020 | $0 | – | 102 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 102 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 102 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 102 | 0.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 102 | -68.2% | 0.00% | – |
Q2 2019 | $2,000 | -33.3% | 321 | +92.2% | 0.00% | – |
Q1 2019 | $3,000 | +50.0% | 167 | +63.7% | 0.00% | – |
Q4 2018 | $2,000 | 0.0% | 102 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | -66.7% | 102 | -70.8% | 0.00% | – |
Q2 2018 | $6,000 | – | 349 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $144,839,000 | 11.40% |
Eversept Partners, LP | 4,755,480 | $32,004,380 | 2.41% |
TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $109,116,000 | 1.27% |
EAM Global Investors LLC | 365,719 | $2,461,000 | 0.68% |
Signature Wealth Management Partners, LLC | 87,666 | $590,000 | 0.57% |
Jackson Creek Investment Advisors LLC | 221,043 | $1,488,000 | 0.52% |
Tranquilli Financial Advisor LLC | 71,414 | $481,000 | 0.39% |
Hillsdale Investment Management Inc. | 611,200 | $4,113,000 | 0.34% |
EAM Investors, LLC | 259,873 | $1,749,000 | 0.26% |
HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $1,211,000 | 0.25% |